目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022 - 2027
Exhibit 14: Chart on Global - Market size and forecast 2022 - 2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022 - 2027 ($ million)
Exhibit 16: Chart on Global Market: Year - over - year growth 2022 - 2027 (%)
Exhibit 17: Data Table on Global Market: Year - over - year growth 2022 - 2027 (%)

4 Historic Market Size
4.1 Global BCL - 2 (B - cell lymphoma 2) inhibitors market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global BCL - 2 (B - cell lymphoma 2) inhibitors market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022 - 2027 (%)
Exhibit 31: Data Table on Product - Market share 2022 - 2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Combination therapy - Market size and forecast 2022 - 2027
Exhibit 34: Chart on Combination therapy - Market size and forecast 2022 - 2027 ($ million)
Exhibit 35: Data Table on Combination therapy - Market size and forecast 2022 - 2027 ($ million)
Exhibit 36: Chart on Combination therapy - Year - over - year growth 2022 - 2027 (%)
Exhibit 37: Data Table on Combination therapy - Year - over - year growth 2022 - 2027 (%)
6.4 Monotherapy - Market size and forecast 2022 - 2027
Exhibit 38: Chart on Monotherapy - Market size and forecast 2022 - 2027 ($ million)
Exhibit 39: Data Table on Monotherapy - Market size and forecast 2022 - 2027 ($ million)
Exhibit 40: Chart on Monotherapy - Year - over - year growth 2022 - 2027 (%)
Exhibit 41: Data Table on Monotherapy - Year - over - year growth 2022 - 2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 44: Chart on Type - Market share 2022 - 2027 (%)
Exhibit 45: Data Table on Type - Market share 2022 - 2027 (%)
7.2 Comparison by Type
Exhibit 46: Chart on Comparison by Type
Exhibit 47: Data Table on Comparison by Type
7.3 Diffuse large B - cell lymphoma (DLBCL) - Market size and forecast 2022 - 2027
Exhibit 48: Chart on Diffuse large B - cell lymphoma (DLBCL) - Market size and forecast 2022 - 2027 ($ million)
Exhibit 49: Data Table on Diffuse large B - cell lymphoma (DLBCL) - Market size and forecast 2022 - 2027 ($ million)
Exhibit 50: Chart on Diffuse large B - cell lymphoma (DLBCL) - Year - over - year growth 2022 - 2027 (%)
Exhibit 51: Data Table on Diffuse large B - cell lymphoma (DLBCL) - Year - over - year growth 2022 - 2027 (%)
7.4 Follicular lymphoma - Market size and forecast 2022 - 2027
Exhibit 52: Chart on Follicular lymphoma - Market size and forecast 2022 - 2027 ($ million)
Exhibit 53: Data Table on Follicular lymphoma - Market size and forecast 2022 - 2027 ($ million)
Exhibit 54: Chart on Follicular lymphoma - Year - over - year growth 2022 - 2027 (%)
Exhibit 55: Data Table on Follicular lymphoma - Year - over - year growth 2022 - 2027 (%)
7.5 Chronic lymphocytic leukemia - Market size and forecast 2022 - 2027
Exhibit 56: Chart on Chronic lymphocytic leukemia - Market size and forecast 2022 - 2027 ($ million)
Exhibit 57: Data Table on Chronic lymphocytic leukemia - Market size and forecast 2022 - 2027 ($ million)
Exhibit 58: Chart on Chronic lymphocytic leukemia - Year - over - year growth 2022 - 2027 (%)
Exhibit 59: Data Table on Chronic lymphocytic leukemia - Year - over - year growth 2022 - 2027 (%)
7.6 Mantle cell lymphoma (MCL) - Market size and forecast 2022 - 2027
Exhibit 60: Chart on Mantle cell lymphoma (MCL) - Market size and forecast 2022 - 2027 ($ million)
Exhibit 61: Data Table on Mantle cell lymphoma (MCL) - Market size and forecast 2022 - 2027 ($ million)
Exhibit 62: Chart on Mantle cell lymphoma (MCL) - Year - over - year growth 2022 - 2027 (%)
Exhibit 63: Data Table on Mantle cell lymphoma (MCL) - Year - over - year growth 2022 - 2027 (%)
7.7 Market opportunity by Type
Exhibit 64: Market opportunity by Type ($ million)
Exhibit 65: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share by geography 2022 - 2027 (%)
Exhibit 68: Data Table on Market share by geography 2022 - 2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022 - 2027
Exhibit 71: Chart on North America - Market size and forecast 2022 - 2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022 - 2027 ($ million)
Exhibit 73: Chart on North America - Year - over - year growth 2022 - 2027 (%)
Exhibit 74: Data Table on North America - Year - over - year growth 2022 - 2027 (%)
9.4 Europe - Market size and forecast 2022 - 2027
Exhibit 75: Chart on Europe - Market size and forecast 2022 - 2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022 - 2027 ($ million)
Exhibit 77: Chart on Europe - Year - over - year growth 2022 - 2027 (%)
Exhibit 78: Data Table on Europe - Year - over - year growth 2022 - 2027 (%)
9.5 Asia - Market size and forecast 2022 - 2027
Exhibit 79: Chart on Asia - Market size and forecast 2022 - 2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022 - 2027 ($ million)
Exhibit 81: Chart on Asia - Year - over - year growth 2022 - 2027 (%)
Exhibit 82: Data Table on Asia - Year - over - year growth 2022 - 2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022 - 2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022 - 2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022 - 2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year - over - year growth 2022 - 2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year - over - year growth 2022 - 2027 (%)
9.7 US - Market size and forecast 2022 - 2027
Exhibit 87: Chart on US - Market size and forecast 2022 - 2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022 - 2027 ($ million)
Exhibit 89: Chart on US - Year - over - year growth 2022 - 2027 (%)
Exhibit 90: Data Table on US - Year - over - year growth 2022 - 2027 (%)
9.8 Canada - Market size and forecast 2022 - 2027
Exhibit 91: Chart on Canada - Market size and forecast 2022 - 2027 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2022 - 2027 ($ million)
Exhibit 93: Chart on Canada - Year - over - year growth 2022 - 2027 (%)
Exhibit 94: Data Table on Canada - Year - over - year growth 2022 - 2027 (%)
9.9 Germany - Market size and forecast 2022 - 2027
Exhibit 95: Chart on Germany - Market size and forecast 2022 - 2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022 - 2027 ($ million)
Exhibit 97: Chart on Germany - Year - over - year growth 2022 - 2027 (%)
Exhibit 98: Data Table on Germany - Year - over - year growth 2022 - 2027 (%)
9.10 UK - Market size and forecast 2022 - 2027
Exhibit 99: Chart on UK - Market size and forecast 2022 - 2027 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2022 - 2027 ($ million)
Exhibit 101: Chart on UK - Year - over - year growth 2022 - 2027 (%)
Exhibit 102: Data Table on UK - Year - over - year growth 2022 - 2027 (%)
9.11 France - Market size and forecast 2022 - 2027
Exhibit 103: Chart on France - Market size and forecast 2022 - 2027 ($ million)
Exhibit 104: Data Table on France - Market size and forecast 2022 - 2027 ($ million)
Exhibit 105: Chart on France - Year - over - year growth 2022 - 2027 (%)
Exhibit 106: Data Table on France - Year - over - year growth 2022 - 2027 (%)
9.12 Market opportunity by geography
Exhibit 107: Market opportunity by geography ($ million)
Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 115: AbbVie Inc. - Overview
Exhibit 116: AbbVie Inc. - Product / Service
Exhibit 117: AbbVie Inc. - Key news
Exhibit 118: AbbVie Inc. - Key offerings
12.4 Abcam plc
Exhibit 119: Abcam plc - Overview
Exhibit 120: Abcam plc - Product / Service
Exhibit 121: Abcam plc - Key news
Exhibit 122: Abcam plc - Key offerings
12.5 Amgen Inc.
Exhibit 123: Amgen Inc. - Overview
Exhibit 124: Amgen Inc. - Product / Service
Exhibit 125: Amgen Inc. - Key offerings
12.6 Ascentage Pharma Group International
Exhibit 126: Ascentage Pharma Group International - Overview
Exhibit 127: Ascentage Pharma Group International - Product / Service
Exhibit 128: Ascentage Pharma Group International - Key offerings
12.7 AstraZeneca Plc
Exhibit 129: AstraZeneca Plc - Overview
Exhibit 130: AstraZeneca Plc - Product / Service
Exhibit 131: AstraZeneca Plc - Key news
Exhibit 132: AstraZeneca Plc - Key offerings
12.8 BeiGene Ltd.
Exhibit 133: BeiGene Ltd. - Overview
Exhibit 134: BeiGene Ltd. - Business segments
Exhibit 135: BeiGene Ltd. - Key offerings
Exhibit 136: BeiGene Ltd. - Segment focus
12.9 Bio Techne Corp.
Exhibit 137: Bio Techne Corp. - Overview
Exhibit 138: Bio Techne Corp. - Business segments
Exhibit 139: Bio Techne Corp. - Key news
Exhibit 140: Bio Techne Corp. - Key offerings
Exhibit 141: Bio Techne Corp. - Segment focus
12.10 Biorbyt Ltd.
Exhibit 142: Biorbyt Ltd. - Overview
Exhibit 143: Biorbyt Ltd. - Product / Service
Exhibit 144: Biorbyt Ltd. - Key offerings
12.11 Bristol Myers Squibb Co.
Exhibit 145: Bristol Myers Squibb Co. - Overview
Exhibit 146: Bristol Myers Squibb Co. - Product / Service
Exhibit 147: Bristol Myers Squibb Co. - Key news
Exhibit 148: Bristol Myers Squibb Co. - Key offerings
12.12 F. Hoffmann La Roche Ltd.
Exhibit 149: F. Hoffmann La Roche Ltd. - Overview
Exhibit 150: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 151: F. Hoffmann La Roche Ltd. - Key news
Exhibit 152: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 153: F. Hoffmann La Roche Ltd. - Segment focus
12.13 Merck and Co. Inc.
Exhibit 154: Merck and Co. Inc. - Overview
Exhibit 155: Merck and Co. Inc. - Business segments
Exhibit 156: Merck and Co. Inc. - Key news
Exhibit 157: Merck and Co. Inc. - Key offerings
Exhibit 158: Merck and Co. Inc. - Segment focus
12.14 Novartis AG
Exhibit 159: Novartis AG - Overview
Exhibit 160: Novartis AG - Business segments
Exhibit 161: Novartis AG - Key offerings
Exhibit 162: Novartis AG - Segment focus
12.15 Santa Cruz Biotechnology Inc.
Exhibit 163: Santa Cruz Biotechnology Inc. - Overview
Exhibit 164: Santa Cruz Biotechnology Inc. - Product / Service
Exhibit 165: Santa Cruz Biotechnology Inc. - Key offerings
12.16 Seagen Inc.
Exhibit 166: Seagen Inc. - Overview
Exhibit 167: Seagen Inc. - Product / Service
Exhibit 168: Seagen Inc. - Key offerings
12.17 Servier
Exhibit 169: Servier - Overview
Exhibit 170: Servier - Business segments
Exhibit 171: Servier - Key offerings
Exhibit 172: Servier - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$
13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources
13.5 List of abbreviations
Exhibit 179: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022 - 2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022 - 2027 ($ million)
Exhibits16: Chart on Global Market: Year - over - year growth 2022 - 2027 (%)
Exhibits17: Data Table on Global Market: Year - over - year growth 2022 - 2027 (%)
Exhibits18: Historic Market Size - Data Table on Global BCL - 2 (B - cell lymphoma 2) inhibitors market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022 - 2027 (%)
Exhibits31: Data Table on Product - Market share 2022 - 2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Combination therapy - Market size and forecast 2022 - 2027 ($ million)
Exhibits35: Data Table on Combination therapy - Market size and forecast 2022 - 2027 ($ million)
Exhibits36: Chart on Combination therapy - Year - over - year growth 2022 - 2027 (%)
Exhibits37: Data Table on Combination therapy - Year - over - year growth 2022 - 2027 (%)
Exhibits38: Chart on Monotherapy - Market size and forecast 2022 - 2027 ($ million)
Exhibits39: Data Table on Monotherapy - Market size and forecast 2022 - 2027 ($ million)
Exhibits40: Chart on Monotherapy - Year - over - year growth 2022 - 2027 (%)
Exhibits41: Data Table on Monotherapy - Year - over - year growth 2022 - 2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Type - Market share 2022 - 2027 (%)
Exhibits45: Data Table on Type - Market share 2022 - 2027 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on Diffuse large B - cell lymphoma (DLBCL) - Market size and forecast 2022 - 2027 ($ million)
Exhibits49: Data Table on Diffuse large B - cell lymphoma (DLBCL) - Market size and forecast 2022 - 2027 ($ million)
Exhibits50: Chart on Diffuse large B - cell lymphoma (DLBCL) - Year - over - year growth 2022 - 2027 (%)
Exhibits51: Data Table on Diffuse large B - cell lymphoma (DLBCL) - Year - over - year growth 2022 - 2027 (%)
Exhibits52: Chart on Follicular lymphoma - Market size and forecast 2022 - 2027 ($ million)
Exhibits53: Data Table on Follicular lymphoma - Market size and forecast 2022 - 2027 ($ million)
Exhibits54: Chart on Follicular lymphoma - Year - over - year growth 2022 - 2027 (%)
Exhibits55: Data Table on Follicular lymphoma - Year - over - year growth 2022 - 2027 (%)
Exhibits56: Chart on Chronic lymphocytic leukemia - Market size and forecast 2022 - 2027 ($ million)
Exhibits57: Data Table on Chronic lymphocytic leukemia - Market size and forecast 2022 - 2027 ($ million)
Exhibits58: Chart on Chronic lymphocytic leukemia - Year - over - year growth 2022 - 2027 (%)
Exhibits59: Data Table on Chronic lymphocytic leukemia - Year - over - year growth 2022 - 2027 (%)
Exhibits60: Chart on Mantle cell lymphoma (MCL) - Market size and forecast 2022 - 2027 ($ million)
Exhibits61: Data Table on Mantle cell lymphoma (MCL) - Market size and forecast 2022 - 2027 ($ million)
Exhibits62: Chart on Mantle cell lymphoma (MCL) - Year - over - year growth 2022 - 2027 (%)
Exhibits63: Data Table on Mantle cell lymphoma (MCL) - Year - over - year growth 2022 - 2027 (%)
Exhibits64: Market opportunity by Type ($ million)
Exhibits65: Data Table on Market opportunity by Type ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2022 - 2027 (%)
Exhibits68: Data Table on Market share by geography 2022 - 2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022 - 2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022 - 2027 ($ million)
Exhibits73: Chart on North America - Year - over - year growth 2022 - 2027 (%)
Exhibits74: Data Table on North America - Year - over - year growth 2022 - 2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022 - 2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022 - 2027 ($ million)
Exhibits77: Chart on Europe - Year - over - year growth 2022 - 2027 (%)
Exhibits78: Data Table on Europe - Year - over - year growth 2022 - 2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022 - 2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022 - 2027 ($ million)
Exhibits81: Chart on Asia - Year - over - year growth 2022 - 2027 (%)
Exhibits82: Data Table on Asia - Year - over - year growth 2022 - 2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022 - 2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022 - 2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year - over - year growth 2022 - 2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year - over - year growth 2022 - 2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022 - 2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022 - 2027 ($ million)
Exhibits89: Chart on US - Year - over - year growth 2022 - 2027 (%)
Exhibits90: Data Table on US - Year - over - year growth 2022 - 2027 (%)
Exhibits91: Chart on Canada - Market size and forecast 2022 - 2027 ($ million)
Exhibits92: Data Table on Canada - Market size and forecast 2022 - 2027 ($ million)
Exhibits93: Chart on Canada - Year - over - year growth 2022 - 2027 (%)
Exhibits94: Data Table on Canada - Year - over - year growth 2022 - 2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022 - 2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022 - 2027 ($ million)
Exhibits97: Chart on Germany - Year - over - year growth 2022 - 2027 (%)
Exhibits98: Data Table on Germany - Year - over - year growth 2022 - 2027 (%)
Exhibits99: Chart on UK - Market size and forecast 2022 - 2027 ($ million)
Exhibits100: Data Table on UK - Market size and forecast 2022 - 2027 ($ million)
Exhibits101: Chart on UK - Year - over - year growth 2022 - 2027 (%)
Exhibits102: Data Table on UK - Year - over - year growth 2022 - 2027 (%)
Exhibits103: Chart on France - Market size and forecast 2022 - 2027 ($ million)
Exhibits104: Data Table on France - Market size and forecast 2022 - 2027 ($ million)
Exhibits105: Chart on France - Year - over - year growth 2022 - 2027 (%)
Exhibits106: Data Table on France - Year - over - year growth 2022 - 2027 (%)
Exhibits107: Market opportunity by geography ($ million)
Exhibits108: Data Tables on Market opportunity by geography ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Abcam plc - Overview
Exhibits120: Abcam plc - Product / Service
Exhibits121: Abcam plc - Key news
Exhibits122: Abcam plc - Key offerings
Exhibits123: Amgen Inc. - Overview
Exhibits124: Amgen Inc. - Product / Service
Exhibits125: Amgen Inc. - Key offerings
Exhibits126: Ascentage Pharma Group International - Overview
Exhibits127: Ascentage Pharma Group International - Product / Service
Exhibits128: Ascentage Pharma Group International - Key offerings
Exhibits129: AstraZeneca Plc - Overview
Exhibits130: AstraZeneca Plc - Product / Service
Exhibits131: AstraZeneca Plc - Key news
Exhibits132: AstraZeneca Plc - Key offerings
Exhibits133: BeiGene Ltd. - Overview
Exhibits134: BeiGene Ltd. - Business segments
Exhibits135: BeiGene Ltd. - Key offerings
Exhibits136: BeiGene Ltd. - Segment focus
Exhibits137: Bio Techne Corp. - Overview
Exhibits138: Bio Techne Corp. - Business segments
Exhibits139: Bio Techne Corp. - Key news
Exhibits140: Bio Techne Corp. - Key offerings
Exhibits141: Bio Techne Corp. - Segment focus
Exhibits142: Biorbyt Ltd. - Overview
Exhibits143: Biorbyt Ltd. - Product / Service
Exhibits144: Biorbyt Ltd. - Key offerings
Exhibits145: Bristol Myers Squibb Co. - Overview
Exhibits146: Bristol Myers Squibb Co. - Product / Service
Exhibits147: Bristol Myers Squibb Co. - Key news
Exhibits148: Bristol Myers Squibb Co. - Key offerings
Exhibits149: F. Hoffmann La Roche Ltd. - Overview
Exhibits150: F. Hoffmann La Roche Ltd. - Business segments
Exhibits151: F. Hoffmann La Roche Ltd. - Key news
Exhibits152: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits153: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits154: Merck and Co. Inc. - Overview
Exhibits155: Merck and Co. Inc. - Business segments
Exhibits156: Merck and Co. Inc. - Key news
Exhibits157: Merck and Co. Inc. - Key offerings
Exhibits158: Merck and Co. Inc. - Segment focus
Exhibits159: Novartis AG - Overview
Exhibits160: Novartis AG - Business segments
Exhibits161: Novartis AG - Key offerings
Exhibits162: Novartis AG - Segment focus
Exhibits163: Santa Cruz Biotechnology Inc. - Overview
Exhibits164: Santa Cruz Biotechnology Inc. - Product / Service
Exhibits165: Santa Cruz Biotechnology Inc. - Key offerings
Exhibits166: Seagen Inc. - Overview
Exhibits167: Seagen Inc. - Product / Service
Exhibits168: Seagen Inc. - Key offerings
Exhibits169: Servier - Overview
Exhibits170: Servier - Business segments
Exhibits171: Servier - Key offerings
Exhibits172: Servier - Segment focus
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations